Infectious Disease and Vaccines Pipeline Reports
Aug 27, 2014
DelveInsight is helping worldwide Pharmaceutical companies with its Market Intelligence Reports.
Downloads
Article in PDF
Recent Articles
- Bristol-Myers Squibb’s Opdivo & Yervoy Combo Trial; Sarepta’s Gene Therapy SRP-9001 for DMD;...
- Reckitt Acquired Mead Johnson; LabCorp’s acquisition; Ferring collaborates; J&J Licenses
- Notizia
- Top 7 Pharma Industry Leaders in 2020 By the Numbers
- Gilead and Merck Announce Encouraging Phase II Results of Islatravir and Lenacapavir Combo; REGEN...
Infectious Diseases and Vaccines
The infectious disease (ID) vaccine pipeline is rich and robust. However, indications such as HIV, Tuberculosis and HCV have high demand for the development of a first vaccine, and even routine vaccinations, such as those for influenza can be improved in terms of safety and efficacy. Such unmet needs are driving the continued development of ID vaccines.
Get Notified About Whats in Others Pipeline
The research work for curing Infectious disease has rapidly assumed a prioritized role within the overall scientific portfolio. The number of vaccines development underway has increased substantially for the HCV, HIV, Tuberculosis and Influenza infections.
Get notified about all the under development vaccines worldwide and the technology they are using, stage of development, their targets, mechanism of action with our Pipeline reports. The best strategic report that will not even give you the overall developing drug profiles but also therapeutic assessment and comparative analysis at every step such as monotherapy, combination, route of administration.
Pipeline Insights Reports
HCV Vaccine-Pipeline Insights, 2014
HIV Vaccine-Pipeline Insights, 2014
Influenza Vaccine-Pipeline Insights, 2014
Tuberculosis Vaccine-Pipeline Insights, 2014
For further information email us at info@delveinsight.com
Downloads
Article in PDF
Recent Articles
- Chronic Inflammatory Demyelinating Polyneuropathy – lack of Effective treatment
- Baxter Introduced New Injectable Pharmaceuticals to US Market; Bayer and Hologic Collaborated to ...
- Duchenne Muscular Dystrophy: Advances, Challenges, and the Future of Treatment
- Merck, Dewpoint’s HIV Pipeline; Pfizer, BioNTech ‘s COVID-19 Vaccines; Roche’s Tecent...
- Notizia
